Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data

Daniel D. Joyce, Kevin M. Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Daniel M. Geynisman, Elizabeth R. Plimack, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data'. Together they form a unique fingerprint.

Medicine & Life Sciences